Collectively, the present results indicate that DYRK1A plays an important role in cognitive function, Aβ/tauopathy and neuroinflammation in WT mice and mouse models of AD, implicating DYRK1A as a potential therapeutic target for AD. Here, DYRK1A is linked to Alzheimer disease.